HRMY Harmony Biosciences Hldgs29.54-4.85 (-14.1%)
HRMY Harmony Biosciences Hldgs34.62-2.30 (-6.2%)
HRMY Harmony Biosciences Hldgs38.91+0.05 (+0.1%)
HRMY Harmony Biosciences Hldgs28.79-3.28 (-10.2%)
Premarket Decliner
HRMY Harmony Biosciences Hldgs32.07-0.35-1.1%
Premarket:29.00-3.07 (-9.6%)
Harmony Biosciences Provides Update From Its Phase 3 RECONNECT Study of ZYN002 in Fragile X Syndrome
Business WireWed, 24-Sep 8:00 AM
HRMY Harmony Biosciences Hldgs33.34-2.49 (-7.0%)